Appendix 4D & Half-year Financial Report - 31 December 2023
Filed with ASX · · 21 pages · English
An explanation of the key financial elements contributing to the revenue and result above can be found in the review of operations included within the Directors’ report. Distributions No dividends have been paid or declared by the Company for the current financial period. No dividends were paid for the previous financial period. Other information required by Listing Rule 4.2A Details of individual
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Appendix 4C & Quarterly Business Update December 2023
- Update - Consolidation/Split - GTG
- Updated Share Consolidation Timetable
- 2023 AGM Presentation
- Consolidation/Split - GTG
Later from Genetic Technologies
- GTG to develop Worlds Most Advanced Comprehensive Risk Test
- GTG to pilot GeneType in Breast Screen centres across the US
- GTG Announces New Precision Oncology Tests
- GTG announces US$2 Million Registered Direct Offering
- Prospectus Supplement
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies